News of Note—APAC adds 50 jobs at Virginia site; New sterile injectable CMO forms

stock market
(Pixabay)  

> China's WuXi Biologics says it is adding commercial manufacturing to the integrated biologics conjugation solution center it is building in Wuxi, China. Release

> Two U.K. contract manufacturers, Cobra Biologics and Symbiosis Pharmaceutical Services, have invested £4.8 million in a collaboration on viral vector manufacturing. Release 

> After making upgrades, API maker AMPAC Fine Chemicals has reopened a plant in Petersburg, Virginia, that has a 50,000-gallon capacity and will add 150 jobs. Release 

> A new CMO has come on the scene with plans to build a $30 million sterile drug manufacturing facility on the West Coast. Story

Read more on